Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares

Obsidian Therapeutics

03/06/2024 13:35

June 3 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA THERAPEUTICS INC SAYS ON MAY 31, CO RECEIVED
WRITTEN
NOTICE FROM NASDAQ INDICATING THAT NASDAQ HEARINGS PANEL
DETERMINED TO DELIST CO’S SHARES
    * GALERA THERAPEUTICS INC SAYS TRADING IN CO’S SHARES OF
COMMON
STOCK ON NASDAQ WILL BE SUSPENDED EFFECTIVE AT OPEN OF TRADING
ON JUNE 4 - SEC FILING
    * GALERA THERAPEUTICS INC - UPON SUSPENSION ON NASDAQ, CO
EXPECTS
COMMON STOCK WILL BE QUOTED UNDER ITS EXISTING SYMBOL “GRTX” ON
OTC

Source text for Eikon:  ID:n0001193125-24-152343 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))